Medical Examination and Clinical Diagnosis

Mutation characteristics of ethambutol resistance gene of Mycobacterium tuberculosis in Guangxi

  • Gang LIU ,
  • Rushu LAN ,
  • Huifang QIN ,
  • Xiaoling QIN ,
  • Yixiang QIN ,
  • Ruolan XU ,
  • Dan. LUO
Expand
  • *.School of Public Health and Management,Guangxi University of Traditional Chinese Medicine,Nanning 530200,China

Received date: 2023-08-30

  Online published: 2024-01-10

Abstract

Objective To investigate the mutation characteristics and influencing factors of ethambutol (EMB) resistance gene of Mycobacterium tuberculosis in Guangxi Zhuang Autonomous region, and to provide evidence for molecular diagnosis and clinical treatment of tuberculosis. Methods A total of 655 strains of Mycobacterium tuberculosis (52 ethambutol resistant strains and 603 ethambutol sensitive strains) were collected continuously from 30 TB drug resistance monitoring sites in Guangxi in 2018-2019, and the mutation characteristics and influencing factors of ethambutol resistant genes were analyzed by whole genome sequencing. Results Among 655 strains of Mycobacterium tuberculosis, 54 strains had ethambutol drug resistance gene mutation, the mutation rate was 8.24% (54/655). Among 52 EMB-resistant strains detected by proportional method, 21 had gene mutation, the mutation rate was 40.38% (21/52), and 33 of 603 EMB-sensitive strains had gene mutation, the mutation rate was 5.47% (33/603). The gene mutation rate in drug-resistant strains was higher than that in sensitive strains (χ 2 =77.133, P = 0.000). The coincidence rate of EMB drug resistance phenotype and gene mutation was 40.38%(21/52), and the results of the two tests were not highly consistent (Kappa = 0.343, P < 0.001). The mutant genes of 54 strains were embA, embB and embC, and there were 20 mutant forms, among which 29 were mutated at unit point, accounting for 53.70% (29/54), and 25 were mutated at joint site, accounting for 46.30% (25/54). Among the unit point mutations, embB306(35.19%) had the highest mutation proportion, followed by embB497 (5.56%) and embB406 (3.70%). Among the joint site mutations, embC270+embB378 had the highest mutation proportion (22.22%),The second was embB306+embA-12 (3.70%). Gender, anti-tuberculosis treatment history, genotype and MDR might be related to EMB gene mutation (χ 2 = 9.388, P = 0.004; χ 2 = 27.084, P = 0.000; χ 2 = 6.671, P = 0.010; χ 2 = 68.826, P = 0.000). Multivariate logistic regression analysis showed that male (OR = 6.150), retreatment (OR = 2.636) and multidrug resistance (OR = 7.333) may be risk factors for EMB resistance gene mutation, and Beijing genotype may be a protective factor for EMB resistance gene mutation (OR = 0.511). Conclusion EMB resistance of Mycobacterium tuberculosis is related to embA, embB and embC gene mutations, and the incidence of EMB resistance phenotype is not high. For male, retreatable, MDR-resistant, and non-Beijing genotype TB patients, attention should be paid to the mutation of the EMB resistance gene.

Cite this article

Gang LIU , Rushu LAN , Huifang QIN , Xiaoling QIN , Yixiang QIN , Ruolan XU , Dan. LUO . Mutation characteristics of ethambutol resistance gene of Mycobacterium tuberculosis in Guangxi[J]. The Journal of Practical Medicine, 2023 , 39(24) : 3261 -3266 . DOI: 10.3969/j.issn.1006-5725.2023.24.020

References

1 JADAUN G P, DAS R, UPADHYAY P,et al. Role of embCAB gene mutations in ethambutol resistance in Mycobacterium tuberculosis isolates from India[J]. Int J Antimicrob Agents, 2009,33(5):483-486.
2 World Health Organization. Global Tuberculosis Report 2021[R/OL]. (2021-10-14). .
3 张春雷,丁豪帅,康亚芬,等. 结核杆菌特异性细胞免疫与结核抗体辅助诊断男性生殖系统结核的价值[J]. 实用医学杂志,2021,37(20):2670-2674.
4 SUN Q, XIAO T Y, LIU H C, et al. Mutations within embCAB Are Associated with Variable Level of Ethambutol Resistance in Mycobacterium tuberculosis Isolates from China[J]. Antimicrob Agents Chemother, 2017,62(1):e01279-17.
5 RAMASWAMY S V, AMIN A G, G?KSEL S, et al. Molecular genetic analysis of nucleotide polymorphisms associated with ethambutol resistance in human isolates of Mycobacterium tuberculosis[J]. Antimicrob Agents Chemother, 2000,44(2):326-336.
6 赵雁林. 结核病实验室检验规程[M]. 北京:人民卫生出版社,2015:39-42,67-70.
7 AMINI S, HOFFNER S, ALLAHYAR TORKAMAN M R, et al. Direct drug susceptibility testing of Mycobacterium tuberculosis using the proportional method: A multicenter study[J]. J Glob Antimicrob Resist, 2019,17:242-244.
8 DE ALMEIDA I N, SILVA CARVALHO W DA, ROSSETTI M L,et al.Evaluation of six different DNA extraction methods for detection of Mycobacterium tuberculosis by means of PCR-IS6110: preliminary study[J]. BMC Res Notes, 2013,6:561.
9 WILSON T M. Clinical experience with ethambutol[J]. Antibiot Chemother,1970,(16):222-229.
10 AHMAD S, MOKADDAS E, AL-MUTAIRI N, et al. Discordance across Phenotypic and Molecular Methods for Drug Susceptibility Testing of Drug-Resistant Mycobacterium tuberculosis Isolates in a Low TB Incidence Country[J]. PLoS One, 2016,11(4):e0153563.
11 BAKULA Z, NAPIORKOWSKA A, BIELECKI J, et al. Mutations in the embB gene and their association with ethambutol resistance in multidrug-resistant Mycobacterium tuberculosis clinical isolates from Poland[J]. Biomed Res Int, 2013,(2013):167954.
12 JIA H, XU Y, SUN Z.Analysis on Drug-Resistance-Associated Mutations among Multidrug-Resistant Mycobacterium tuberculosis Isolates in China[J]. Antibiotics (Basel), 2021,10(11):1367.
13 PLINKE C, RUSCH GERDES S, NIEMANN S. Significance of mutations in embB codon 306 for prediction of ethambutol resistance in clinical Mycobacterium tuberculosis isolates[J]. Antimicrob Agents Chemother, 2006,50(5):1900-1902.
14 MOKROUSOV I, OTTEN T, VYSHNEVSKIY B, et al. Detection of embB306 mutations in ethambutol-susceptible clinical isolates of Mycobacterium tuberculosis from Northwestern Russia: implications for genotypic resistance testing[J]. J Clin Microbiol,2002,40(10):3810-3813.
15 SHI D, LI L, ZHAO Y, et al. Characteristics of embB mutations in multidrug-resistant Mycobacterium tuberculosis isolates in Henan, China[J]. J Antimicrob Chemother, 2011,66(10):2240-2247.
16 SAFI H, LINGARAJU S, AMIN A, et al. Evolution of high-level ethambutol-resistant tuberculosis through interacting mutations in decaprenylphosphoryl-β-D-arabinose biosynthetic and utilization pathway genes[J]. Nat Genet, 2013,45(10):1190-1197.
17 KHOSRAVI A D, SIROUS M, ABDI M, et al. Characterization of the most common embCAB gene mutations associated with ethambutol resistance in Mycobacterium tuberculosis isolates from Iran[J]. Infect Drug Resist, 2019,12:579-584.
18 XIANG X, GONG Z, DENG W, et al. Mycobacterial ethambutol responsive genes and implications in antibiotics resistance[J]. J Drug Target, 2021,29(3):284-293.
19 车洋,杨天池,平国华,等. 宁波地区耐多药结核分枝杆菌乙胺丁醇耐药embB基因突变研究[J]. 中国预防医学杂志, 2018,19(7):505-508.
20 刘厚明,曾敏,李全,等. embB基因突变与乙胺丁醇药敏表型及耐多药关系的研究[J]. 分子诊断与治疗杂志, 2017,9(1):16-22,32.
21 XU Y, JIA H, HUANG H, et al. Mutations Found in embCAB, embR, and ubiA Genes of Ethambutol-Sensitive and -Resistant Mycobacterium tuberculosis Clinical Isolates from China[J]. Biomed Res Int, 2015,2015:951706.
22 SAFI H, FLEISCHMANN R D, PETERSON S N, et al. Allelic exchange and mutant selection demonstrate that common clinical embCAB gene mutations only modestly increase resistance to ethambutol in Mycobacterium tuberculosis[J]. Antimicrob Agents Chemother, 2010,54(1):103-108.
23 吴坤阳,陆烨玮,张明五,等. 浙江省结核分枝杆菌耐药突变特征及其与基因型相关性分析[J]. 中国防痨杂志, 2022,44(11):1126-1134.
24 孙庆. 结核分枝杆菌乙胺丁醇耐药性与分子特征的相关性研究[D]. 衡阳:南华大学, 2015.
25 刘翠玉,历素萍,潘宝山,等. 2017-2020年黑龙江省佳木斯市肺结核患者耐药情况分析[J]. 疾病监测, 2021,36(10):1052-1056.
26 郑扬,赵雁林. 初、复治患者结核分枝杆菌临床分离株对抗结核药物耐药性的分析[J]. 医学研究杂志, 2017,46(4):22-27.
27 MOHAMMADI B, RAMAZANZADEH R, NOURI B,et al. Frequency of Codon 306 Mutations in embB Gene of Mycobacterium tuberculosis Resistant to Ethambutol: A Systematic Review and Meta-Analysis[J]. Int J Prev Med, 2020,11:112.
28 徐东芳,刘海灿,赵秀芹,等. 391株结核分枝杆菌基因分型研究和耐药性分析[J]. 中国卫生检验杂志, 2016,26(18):2719-2720,2731.
Outlines

/